Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Henry Schein (NASDAQ:HSIC) on Wednesday, setting a price target of $84, which is approximately 6.45% above...
Henry Schein Inc (NASDAQ: HSIC) raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus.It posted an adjusted EPS of $1.24 ahead of the...
Investing.com - Henry Schein (NASDAQ:HSIC) reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Henry Schein announced...
The following slide deck was published by Henry Schein, Inc.
For Immediate ReleaseChicago, IL – January 22, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 320.02 | 320.24 | 313.28 | +5.00 | +1.59% | 19.01M | NASDAQ | |||
| 2,337.35 | 2,337.35 | 2,293.04 | +22.58 | +0.98% | 1.26M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 156.52 | 156.62 | 151.48 | +4.40 | +2.89% | 588.11K | NYSE | |||
| 15.93 | 16.29 | 15.02 | +0.99 | +6.63% | 8.64M | NYSE | |||
| 7.59 | 7.71 | 7.34 | +0.29 | +3.97% | 16.22M | NYSE | |||
| 1.15 | 1.22 | 1.11 | -0.0500 | -4.17% | 21.94M | NYSE | |||
| 7.18 | 7.58 | 7.08 | -0.390 | -5.15% | 355.67K | NASDAQ | |||
| 40.45 | 40.45 | 40.45 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.8223 | 0.00 | 0.00 | +0.0228 | +2.85% | 3.71M | NYSE | |||
| 69.28 | 69.41 | 67.90 | +1.35 | +1.99% | 455.74K | NYSE | |||
| 20.09 | 21.02 | 19.41 | -1.06 | -5.01% | 92.20M | NYSE | |||
| 161.01 | 164.72 | 155.60 | +1.53 | +0.96% | 2.94M | NYSE | |||
| 152.85 | 159.13 | 150.00 | -14.30 | -8.56% | 2.55M | NYSE | |||
| 25.82 | 25.85 | 25.63 | +0.04 | +0.15% | 1.45K | NYSE |
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.